YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
8.88
+0.46 (5.40%)
Feb 26, 2026, 2:56 PM EST - Market open
YD Bio Market Cap
YD Bio has a market cap or net worth of $624.44 million as of February 26, 2026. Its market cap has increased by 1,274.83% in one year.
Market Cap
624.44M
Enterprise Value
628.36M
1-Year Change
1,274.83%
Ranking
Category
Stock Price
$8.88
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $624.44M, an increase of 320.91%. That is a compound annual growth rate of 31.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 592.44M | -30.89% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 607.43M |
| MeiraGTx Holdings | 606.90M |
| Prime Medicine | 591.31M |
| Design Therapeutics | 589.57M |
| Neumora Therapeutics | 586.29M |
| Contineum Therapeutics | 571.32M |
| Alto Neuroscience | 568.51M |
| Altimmune | 566.05M |